|
Real-time Estimate
Cboe BZX
23:16:00 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 12.11 USD | +6.79% |
|
+1.29% | +221.88% |
| 09-25 | SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer | CI |
| 09-14 | Top Premarket Decliners | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SLS | Delayed | |
CBOE
| SLS | Real-time | |
|
Tradegate
| RXK3 | Real-time | |
|
Boerse Muenchen
| RXK3 | Real-time | |
|
Börse Stuttgart
| RXK3 | Delayed | |
|
Deutsche Boerse AG
| RXK3 | Delayed | |
|
Xetra
| RXK3 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 12.41 | 15.46 | 15.46 |
| Spread/Res. | -2.22% | -21.51% | -21.51% |
| Spread/Supp. | +21.59% | +41.93% | +72.13% |
| Support | 9.98 | 8.55 | 7.05 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SLS Stock
- Charts SELLAS Life Sciences Group, Inc.
Select your edition
All financial news and data tailored to specific country editions
